Dimethyl Fumarate DR Presolicitation

The Defense Logistics Agency (DLA) Troop Support is conducting a fully competitive, unrestricted procurement for a national requirements contract to supply Dimethyl Fumarate delayed-release (DR) capsules, specifically 120 mg in 14-count bottles and 240 mg in 60-count bottles. This firm-fixed price, requirements-type contract includes a one-year base period with four one-year option periods. It aims to establish a reliable national supply source for Department of Defense customers through the DLA prime vendor program and will follow commercial item acquisition procedures under FAR Part 12. Estimated annual usage quantities will be provided in the solicitation schedule. Interested suppliers can submit offers via the Defense Logistics Agency Internet Bid Board System (DIBBS), and all proposals will be fairly considered. The solicitation and related amendments have been posted on DIBBS and Beta.SAM.gov, with the initial solicitation release and subsequent amendments adjusting due dates and clarifying submission instructions to ensure clear communication with potential offerors. Since the initial solicitation release, several amendments have been issued to extend offer due dates and correct timeframes, providing ample opportunity for vendors to respond. Additionally, contract modifications have exercised option periods to extend performance through October 2025 under the current Dimethyl Fumarate DR contract. These modifications affirm that all other contract terms remain consistent, aligning with FAR clauses pertaining to contract extensions. The points of contact, including Kevin Rafferty, support vendor inquiries and facilitate information flow. Overall, this contract supports the consistent and uninterrupted supply of crucial pharmaceutical products to meet defense medical logistics needs, emphasizing transparency, competition, and adherence to federal acquisition regulations.